Should employers cover GLP-1s? Three considerations
from a chief medical officer
In recent months, weight management and the search for healthcare guidance on promising GLP-1 drugs has become a frequent topic of discussion Patients are looking to improve their health and, ultimately, their quality of life, while employers are wondering how they should address GLP-1s as part of their health benefits offering. The current swirl of debate in the news media and in the market raises questions about the cost and appropriate utilization of GLP-1s This has left some employers pondering about whether they should cover these drugs at all.
Read this article to learn about additional considerations before developing your organizations GLP-1 strategy.